| |
|
|
|
Calithera Biosciences Inc.  
|
|
3.82 -0.03 (-0.01%) |
08-23 16:00 |
|
Open: |
3.83 |
Pre close: |
3.85 |
Target:
|
4.72
|
|
High: |
3.92 |
Low: |
3.76 |
Resistance:
|
4.04
4.40
|
|
Volume: |
251,688 |
Market Cap: |
205M |
Support:
|
3.45
2.87
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.94
 |
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
3.97 |
Signal(12,26,9): |
-0.11  |
|
MA(100): |
5.04 |
Stochastic Oscillator |
%K(14,3):
|
52.65 |
|
MA(250): |
5.08 |
%D(3): |
55.05 |
|
Average Volume(K) |
3-Month: |
45842
|
52-Week |
High:
|
6.90 |
|
10-Days: |
23173 |
Low: |
3.43 |
|
RSI |
RSI(14):
|
42.89 |
Change(%): |
-19.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.225 |
Return on Equity (ttm) |
-60.2 |
Shares Out. (M) |
39.24 |
|
EPS Est. Current Year |
-0.810 |
Return on Assets (ttm) |
-34.2 |
Shares Float (M) |
46.36 |
|
EPS Est. Next Year |
-1.050 |
PEG Ratio |
-0.03 |
% Held by Insiders |
1.31 |
|
EPS Est. Next Quarter |
-0.230 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
67.90 |
|
Forward EPS |
-1.879 |
Gross Profit (p.s.) |
-1.120 |
Shares Short (K) |
913 |
|
Book Value (p.s.) |
2.590 |
EBITDA (p.s.) |
-2.256 |
P/E |
-1.72 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.47 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-71.12 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-40.03 |
P/CF |
-2.11 |
|
|
|
|
|
|
